The inhibition of tankyrase is reported to exhibit an anti-cancer effect against BRCA1/2-deficient and Wnt-dependent cancers as well as a universal anti-cancer effect through the stabilization of TRF1 and a concomitant inhibition of telomerase function [1,2]. This evidence concerns the gene TERF1 and cancer.